Abstract: The present invention relates to the branches of Biotechnology and Medicine. It describes the use of therapeutic compositions comprising a compound that blocks epidermal growth factor and an antibody that blocks the PD-1/PD-1 ligand signaling pathway in the treatment of tumors of epithelial origin, particularly those that express the native form for human KRAS protein. In patients with cancer of epithelial origin expressing native KRAS treated with said therapeutic compositions, an increase in their survival was observed.

Abstract: A coded pocket liner system having a first translucent flexible bag of a first predetermined size having a first color-coded indicium and a closure device disposed at an open end thereof. The first translucent flexible bag is adapted for insertion into a pouch. A second translucent flexible bag of a second predetermined size includes a second color-coded indicium and a closure device disposed at an open end thereof. The second translucent flexible bag is adapted for insertion into the pouch.

Abstract: Thermoplastic elastomer film vacuum bags are provided which readily conform to the surface contour of the workpiece at low pressures without failure. The thermoplastic elastomer film can be made into thin films which are able to withstand higher pressures and temperatures than the prior art nylon films. The films can also withstand the presence of epoxide and phenolic resins during pressure and cure without degradation. Preferred thermoplastic elastomers are block copolymers such as Hytrel. The films are pliable and can be used with minimal or no pleating.